Thanks for ur reply.
Actually in ur output everything is fine.
just I want this shuld not move to left hand side and shuld remain at its place as it was in input for CHRM1 same for FLT1. tht's it. Kindly inform me whether I hae to attache data sample list?
Glycopyrrolate DAP001116 Anesthetic Approved T2D
Clidinium DAP001117 Abdominal/stomach pain Approved T2D
Dicyclomine DAP001118 Irritable bowel syndrome Approved T2D
Ethopropazine DAP001119 Parkinson's disease Approved T2D
Cycrimine DAP001120 Parkinson's disease Approved T2D
Benztropine DAP001121 Parkinson's disease Approved T2D
Trihexyphenidyl DAP001122 Parkinson's disease Approved T2D
Propantheline DAP001123 Excessive sweating (hyperhidrosis) Approved T2D
Oxyphenonium DAP001124 Spasm Approved T2D
Biperiden DAP001125 Parkinson's disease Approved T2D
Talsaclidine isomer DCL000268 Alzheimer's disease Discontinued T2D
Sabcomeline hydrochloride DCL000279 Cardiovascular diseases Phase IIa T2D
Talsaclidine fumarate DCL000303 Alzheimer's disease Discontinued T2D
Xanomeline tartrate DCL000328 Alzheimer's disease Phase II T2D
GSK573719 DCL000381 Chronic Obstructive Pulmonary Disease (COPD) Phase II T2D
GSK961081 DCL000397 Chronic Obstructive Pulmonary Disease (COPD) Phase II completed T2D
GSK1034702 DCL000402 Schizophrenia, Dementia Phase I completed T2D
Darotropium DCL000514 COPD Suspended in Phase II in GSK 2009 Report T2D
+ 642444 DCL000515 COPD Phase III T2D
Revatropate DCL000957 Chronic obstructive pulmonary disease Discontinued in Phase I T2D